Lupin share price jumps over 3% to hit 52-week high on US FDA approval for drugs
Lupin stock price today rose 3.8% to touch a 52-week high after receiving US FDA approval for two drug. Lupin's stock price has returned over 67% this year, supported by good volumes and positive trend.
DNA News Desk
0
2
Lupin stock price today rose 3.8% to touch a 52-week high after receiving US FDA approval for two drug. Lupin's stock price has returned over 67% this year, supported by good volumes and positive trend.
